期刊文献+

CD34与PCNA基因表达在肝细胞腺瘤与甲胎蛋白阴性肝细胞肝癌鉴别诊断中的意义

CD34 and PCNA gene expression and significance in the differential diagnosis of hepatocellular adenomas and hepatocellular carcinoma with negative alpha fetal protein
下载PDF
导出
摘要 目的研究内皮细胞标记物(CD34)、增殖细胞核抗原(PCNA)蛋白在肝细胞腺瘤(hepatocellular adenoma,HA)与甲胎蛋白(AFP)阴性肝细胞肝癌(hepatocellular carcinoma,HCC)中的免疫组化表达情况,探讨CD34、PCNA在HA与AFP阴性HCC中表达的差异性。方法分别采用免疫组织化学(immunohistochemistry,IHC)SP两步法染色,观察HA与AFP阴性HCC中CD34、PCNA的蛋白表达情况并进行对比。结果 16例HA中CD34与PCNA均呈现低表达,80例AFP阴性HCC中CD34与PCNA均呈现高表达。其中,CD34表达的平均秩次值分别为26.97和52.81,AFP阴性HCC中CD34的阳性表达高于HA,二者比较差异有统计学意义(P<0.01)。PCNA表达的平均秩次值分别为14.22和55.36,AFP阴性HCC中PCNA的阳性表达明显高于HA,二者比较差异有统计学意义(P<0.01)。结论 CD34与PCNA在HA与AFP阴性HCC中表达差异显著,可以为两类疾病的鉴别诊断提供分子生物学依据。 Objective To detect the expression of CD34,PCNA in the hepatocellular adenoma (HA) and hepatocellular carcinoma ( HCC ) with negative alpha fetal protein (AFP) and discuss the expression differences of CD3g, PCNA between HA and AFP negative HCC. Methods Immunohistochemistry ( IHC) SP two-step staining was used respectively to observe the expression of CD34 and PC- NA protein in the tissue of HA and AFP negative HCC. Results In 16 cases of HA, CD34 and PCNA showed low expression. CD34 and PCNA showed high expression in the 80 cases of AFP negative HCC. Among them', the mean rank values of CD34 expression were 26. 97 and 52.81, the CD34 positive expression of AFP negative HCC was higher than HA, P 〈 0.01. The mean rank values of PCNA expression were 14. 22 and 55.36, the PCNA positive expression of AFP negative HCC was higher than HA, P 〈 0. 01. Conclusion The expression differences of CD3g and PCNA in HA and AFP negative HCC contribute to the differential diagnosis of the two diseases.
出处 《滨州医学院学报》 2013年第2期90-93,共4页 Journal of Binzhou Medical University
关键词 肝腺瘤 AFP阴性肝癌 免疫组化 鉴别诊断 Hepatoeellular adenomas, hepatocellular carcinoma with negative alpha fetal protein, immunohistochemistry, differentialdiagnosis
  • 相关文献

参考文献13

  • 1Cross-Ref M, Bioulac-Sage P, Balabaud C,et al. Subtype classifica-tion of hepatocellular adenoma[ J]. Dig Surg,2010, 27 (1) :39-45.
  • 2Cross-Ref M, Zucman-Rossi J, Jeannot E, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and rela- tionship with HCC [ J ]. Hepatology, 2006,43 ( 3 ) :515-524.
  • 3丛文铭,谭璐,张树辉,冼志红,吴伟清,潘晶,张秀忠.肝癌免疫组化诊断谱的研究和应用[J].中华肿瘤杂志,2002,24(6):553-556. 被引量:28
  • 4Luciani A, Kobeiter H, Maison P,et al. Focal nodular hyperplasia of the liver in men : is presentation the same in men and women [ J ] .9 Gut, 2002,50 ( 6 ) : 877-880.
  • 5Schild H, Kreitner KF, Thelen M, et al. Focal nodular hyperplasia of the liver in 930 patients [J]. Rofo, 1987,147 (6) :612-618.
  • 6胡迎宾,李定国,陆汉明,吴建新.甲胎蛋白阴性肝癌的临床特点分析[J].实用医学杂志,2006,22(5):550-551. 被引量:7
  • 7Ogden SK, Lee KC, Barton MC. Hepatitis B viral transactivator HBx alleviates p53-mediated represstion of alpha-fetoprotein gene expre- sstion [ J ]. J Biol Chem,2000,275 ( 36 ) :27806-27814.
  • 8Hytiroglou P, Fheise ND. Differential diagnosis of hepatocellular nod- ular lesions [ J ]. Semi in Diag Pathol, 1998,15 ( 3 ) : 285-298.
  • 9Stroescu C, Draqnea A, Ivanov B, et al. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma [ J ]. J Gastrointestin Liver Dis ,2008,17 (4) :411-417.
  • 10Venturi A, Piaz FD, Giovannini C, et al. Human hepatocellular car- cinoma expresses specific PCNA isoforms: an in vivo and in vitro e- valuation [ J] Lab Invest, 2008,88 ( 9 ) :955-1007.

二级参考文献32

  • 1Hamilton SR, Aahonen LA. World Health Organization Classification of Tumours: Pathology and genetics of tumours of the digestive system[M]. Lyon: IARC Press, 2000.
  • 2Kondo F. Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: Etiological analysis and introduction of a new concept[J]. J Gastroenterol Hepatol, 2001, 16(12):1319-1328.
  • 3Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma[J]. J Hepatol, 2008, 48(1):163-170.
  • 4Gong L, Li YH, Su Q, et al. Use of X-chromosome inactivation pattern and laser microdissection to determine the clonal origin of focal nodular hyperplasia of the liver [J]. Pathology, 2009,41(4):348-355.
  • 5Bioulac-Sage P, Rebouissou S, Sa Cunha A, et al. Clinical, morphologic, and molecular features defining socalled telangiectatic focal nodular hyperplasias of the liver[J].Gastroenterology, 2005,128 (5): 1211-1218.
  • 6Rebouissou S, Amessou M, Couchy G, et al. Frequent inframe somatic deletions activate gp130 in inflammatory hepatocellular tumours[J]. Nature, 2009,457 (7226):200- 204.
  • 7Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotypephenotype correlation in hepatocellular adenoma: new classification and relationship with HCC [J]. Hepatology, 2006,43(3):515-524.
  • 8Deneve JL, Pawlik TM, Cunningham S, et al. Liver cell adenoma: a muhicenter analysis of risk factors for rupture and malignancy[J]. Ann Surg Oncol, 2009,16(3): 640- 648.
  • 9Chebib I, Shabani-Rad MT, Chow MS, et al. Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis[J]. Biomark Insights, 2007,2:59-68.
  • 10Kato K, Kawashiri S, Yoshizawa K, et al. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis [J].J Oral Pathol Med,2011,40(9) :693-698.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部